ペルオキシソーム増殖因子活性化受容体デルタの世界市場レポート2020

• 英文タイトル：Global Peroxisome Proliferator Activated Receptor Delta Sales Market Report 2020

• レポートコード：20QY06-03644 • 出版社/出版日：QYResearch / 2020年6月1日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、135ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療

• 販売価格（消費税別）

Single User	￥592,000 (USD4,000)	▷ お問い合わせ
Multi User	￥888,000 (USD6,000)	▷ お問い合わせ
Enterprise License	￥1,184,000 (USD8,000)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社の当調査資料では、ペルオキシソーム増殖因子活性化受容体デルタのグローバル市場について種類別（MTB-2、HPP-593、CNX-013B2、CS-038、MA-0204、その他）、用途別（骨疾患、大腸炎、肥満、骨粗しょう症、その他）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・ペルオキシソーム増殖因子活性化受容体デルタ市場の概要 ・世界の主要地域別ペルオキシソーム増殖因子活性化受容体デルタ市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のペルオキシソーム増殖因子活性化受容体デルタ市場規模2015-2026：種類別（MTB-2、HPP-593、CNX-013B2、CS-038、MA-0204、その他） ・世界のペルオキシソーム増殖因子活性化受容体デルタ市場規模2015-2026：用途別（骨疾患、大腸炎、肥満、骨粗しょう症、その他） ・ペルオキシソーム増殖因子活性化受容体デルタの北米市場規模2015-2020 ・ペルオキシソーム増殖因子活性化受容体デルタのヨーロッパ市場規模2015-2020 ・ペルオキシソーム増殖因子活性化受容体デルタの中国市場規模2015-2020 ・ペルオキシソーム増殖因子活性化受容体デルタの日本市場規模2015-2020 ・ペルオキシソーム増殖因子活性化受容体デルタの東南アジア市場規模2015-2020 ・ペルオキシソーム増殖因子活性化受容体デルタのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Chipscreen Biosciences Ltd、Connexios Life Sciences Pvt Ltd、CymaBay Therapeutics Inc、Genfit SA、Inventiva、Mitobridge Inc、Nippon Chemiphar Co Ltd、Senju Pharmaceutical Co Ltd、T3D Therapeutics Inc） ・ペルオキシソーム増殖因子活性化受容体デルタの製造コスト分析 ・販売チャネル、流通業者、顧客 ・ペルオキシソーム増殖因子活性化受容体デルタの市場動向・機会・課題 ・調査の結論

Market Analysis and Insights: Global Peroxisome Proliferator Activated Receptor Delta Market
The global Peroxisome Proliferator Activated Receptor Delta market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026.
Global Peroxisome Proliferator Activated Receptor Delta Scope and Market Size
The global Peroxisome Proliferator Activated Receptor Delta market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Peroxisome Proliferator Activated Receptor Delta market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Peroxisome Proliferator Activated Receptor Delta market is segmented into
MTB-2
HPP-593
CNX-013B2
CS-038
MA-0204
Others

Segment by Application, the Peroxisome Proliferator Activated Receptor Delta market is segmented into
Bone Disorders
Colitis
Obesity
Osteoporosis
Others
The Peroxisome Proliferator Activated Receptor Delta market is analysed and market size information is provided by regions (countries). Segment by Application, the Peroxisome Proliferator Activated Receptor Delta market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Peroxisome Proliferator Activated Receptor Delta Market Share Analysis
Peroxisome Proliferator Activated Receptor Delta market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Peroxisome Proliferator Activated Receptor Delta business, the date to enter into the Peroxisome Proliferator Activated Receptor Delta market, Peroxisome Proliferator Activated Receptor Delta product introduction, recent developments, etc.
The major vendors covered:
Chipscreen Biosciences Ltd
Connexios Life Sciences Pvt Ltd
CymaBay Therapeutics Inc
Genfit SA
Inventiva
Mitobridge Inc
Nippon Chemiphar Co Ltd
Senju Pharmaceutical Co Ltd
T3D Therapeutics Inc

レポート目次

---

Table of Contents

1 Peroxisome Proliferator Activated Receptor Delta Market Overview
1.1 Peroxisome Proliferator Activated Receptor Delta Product Scope
1.2 Peroxisome Proliferator Activated Receptor Delta Segment by Type
1.2.1 Global Peroxisome Proliferator Activated Receptor Delta Sales by Type (2020-2026)
1.2.2 MTB-2
1.2.3 HPP-593
1.2.4 CNX-013B2
1.2.5 CS-038
1.2.6 MA-0204
1.2.7 Others
1.3 Peroxisome Proliferator Activated Receptor Delta Segment by Application
1.3.1 Global Peroxisome Proliferator Activated Receptor Delta Sales Comparison by Application (2020-2026)
1.3.2 Bone Disorders
1.3.3 Colitis
1.3.4 Obesity
1.3.5 Osteoporosis
1.3.6 Others
1.4 Peroxisome Proliferator Activated Receptor Delta Market Estimates and Forecasts (2015-2026)
1.4.1 Global Peroxisome Proliferator Activated Receptor Delta Sales Growth Rate (2015-2026)
1.4.2 Global Peroxisome Proliferator Activated Receptor Delta Revenue and Growth Rate (2015-2026)
1.4.3 Global Peroxisome Proliferator Activated Receptor Delta Price Trends (2015-2026)

2 Peroxisome Proliferator Activated Receptor Delta Estimate and Forecast by Region
2.1 Global Peroxisome Proliferator Activated Receptor Delta Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Peroxisome Proliferator Activated Receptor Delta Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Peroxisome Proliferator Activated Receptor Delta Sales Market Share by Region (2015-2020)
2.2.2 Global Peroxisome Proliferator Activated Receptor Delta Revenue Market Share by Region (2015-2020)
2.3 Global Peroxisome Proliferator Activated Receptor Delta Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Peroxisome Proliferator Activated Receptor Delta Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Peroxisome Proliferator Activated Receptor Delta Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Peroxisome Proliferator Activated Receptor Delta Estimates and Projections (2015-2026)
2.4.2 Europe Peroxisome Proliferator Activated Receptor Delta Estimates and Projections (2015-2026)
2.4.3 China Peroxisome Proliferator Activated Receptor Delta Estimates and Projections (2015-2026)
2.4.4 Japan Peroxisome Proliferator Activated Receptor Delta Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Peroxisome Proliferator Activated Receptor Delta Estimates and Projections (2015-2026)
2.4.6 India Peroxisome Proliferator Activated Receptor Delta Estimates and Projections (2015-2026)
3 Global Peroxisome Proliferator Activated Receptor Delta Competition Landscape by Players
3.1 Global Top Peroxisome Proliferator Activated Receptor Delta Players by Sales (2015-2020)
3.2 Global Top Peroxisome Proliferator Activated Receptor Delta Players by Revenue (2015-2020)
3.3 Global Peroxisome Proliferator Activated Receptor Delta Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Peroxisome Proliferator Activated Receptor Delta as of 2019)
3.4 Global Peroxisome Proliferator Activated Receptor Delta Average Price by Company (2015-2020)
3.5 Manufacturers Peroxisome Proliferator Activated Receptor Delta Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Peroxisome Proliferator Activated Receptor Delta Players (Opinion Leaders)
4 Global Peroxisome Proliferator Activated Receptor Delta Market Size by Type
4.1 Global Peroxisome Proliferator Activated Receptor Delta Historic Market Review by Type (2015-2020)
4.1.1 Global Peroxisome Proliferator Activated Receptor Delta Sales Market Share by Type (2015-2020)
4.1.2 Global Peroxisome Proliferator Activated Receptor Delta Revenue Market Share by Type (2015-2020)
4.1.3 Global Peroxisome Proliferator Activated Receptor Delta Price by Type (2014-2020)
4.2 Global Peroxisome Proliferator Activated Receptor Delta Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Peroxisome Proliferator Activated Receptor Delta Sales Forecast by Type (2021-2026)
4.2.2 Global Peroxisome Proliferator Activated Receptor Delta Revenue Forecast by Type (2021-2026)
4.2.3 Global Peroxisome Proliferator Activated Receptor Delta Price Forecast by Type (2021-2026)
5 Global Peroxisome Proliferator Activated Receptor Delta Market Size by Application
5.1 Global Peroxisome Proliferator Activated Receptor Delta Historic Market Review by Application (2015-2020)
5.1.1 Global Peroxisome Proliferator Activated Receptor Delta Sales Market Share by Application (2015-2020)
5.1.2 Global Peroxisome Proliferator Activated Receptor Delta Revenue Market Share by Application (2015-2020)
5.1.3 Global Peroxisome Proliferator Activated Receptor Delta Price by Application (2015-2020)
5.2 Global Peroxisome Proliferator Activated Receptor Delta Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Peroxisome Proliferator Activated Receptor Delta Sales Forecast by Application (2021-2026)
5.2.2 Global Peroxisome Proliferator Activated Receptor Delta Revenue Forecast by Application (2021-2026)
5.2.3 Global Peroxisome Proliferator Activated Receptor Delta Price Forecast by Application (2021-2026)

3 North America Peroxisome Proliferator Activated Receptor Delta Market Facts & Figures
3.2 North America Peroxisome Proliferator Activated Receptor Delta Sales Market Share by Company (2015-2020)
3.3 North America Peroxisome Proliferator Activated Receptor Delta Sales Market Share by Type (2015-2020)
3.4 North America Peroxisome Proliferator Activated Receptor Delta Sales Market Share by Application (2015-2020)

4 Europe Peroxisome Proliferator Activated Receptor Delta Market Facts & Figures
4.2 Europe Peroxisome Proliferator Activated Receptor Delta Sales Market Share by Company (2015-2020)
4.3 Europe Peroxisome Proliferator Activated Receptor Delta Sales Market Share by Type (2015-2020)
4.4 Europe Peroxisome Proliferator Activated Receptor Delta Sales Market Share by Application (2015-2020)

5 China Peroxisome Proliferator Activated Receptor Delta Market Facts & Figures
5.2 China Peroxisome Proliferator Activated Receptor Delta Sales Market Share by Company (2015-2020)
5.3 China Peroxisome Proliferator Activated Receptor Delta Sales Market Share by Type (2015-2020)
5.4 China Peroxisome Proliferator Activated Receptor Delta Sales Market Share by Application (2015-2020)

6 Japan Peroxisome Proliferator Activated Receptor Delta Market Facts & Figures
6.2 Japan Peroxisome Proliferator Activated Receptor Delta Sales Market Share by Company (2015-2020)
6.3 Japan Peroxisome Proliferator Activated Receptor Delta Sales Market Share by Type (2015-2020)
6.4 Japan Peroxisome Proliferator Activated Receptor Delta Sales Market Share by Application (2015-2020)

7 Southeast Asia Peroxisome Proliferator Activated Receptor Delta Market Facts & Figures
7.2 Southeast Asia Peroxisome Proliferator Activated Receptor Delta Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Peroxisome Proliferator Activated Receptor Delta Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Peroxisome Proliferator Activated Receptor Delta Sales Market Share by Application (2015-2020)

8 India Peroxisome Proliferator Activated Receptor Delta Market Facts & Figures
8.2 India Peroxisome Proliferator Activated Receptor Delta Sales Market Share by Company (2015-2020)
8.3 India Peroxisome Proliferator Activated Receptor Delta Sales Market Share by Type (2015-2020)
8.4 India Peroxisome Proliferator Activated Receptor Delta Sales Market Share by Application (2015-2020)

12 Company Profiles and Key Figures in Peroxisome Proliferator Activated Receptor Delta Business
12.1 Chipscreen Biosciences Ltd
12.1.1 Chipscreen Biosciences Ltd Peroxisome Proliferator Activated Receptor Delta Corporation Information
12.1.2 Chipscreen Biosciences Ltd Peroxisome Proliferator Activated Receptor Delta Business Overview and Total Revenue
12.1.3 Chipscreen Biosciences Ltd Peroxisome Proliferator Activated Receptor Delta Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Chipscreen Biosciences Ltd Peroxisome Proliferator Activated Receptor Delta Products Offered
12.1.5 Chipscreen Biosciences Ltd Recent Development
12.2 Connexios Life Sciences Pvt Ltd
12.2.1 Connexios Life Sciences Pvt Ltd Peroxisome Proliferator Activated Receptor Delta Corporation Information
12.2.2 Connexios Life Sciences Pvt Ltd Peroxisome Proliferator Activated Receptor Delta Business Overview and Total Revenue
12.2.3 Connexios Life Sciences Pvt Ltd Peroxisome Proliferator Activated Receptor Delta Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Connexios Life Sciences Pvt Ltd Peroxisome Proliferator Activated Receptor Delta Products Offered
12.2.5 Connexios Life Sciences Pvt Ltd Recent Development
12.3 CymaBay Therapeutics Inc
12.3.1 CymaBay Therapeutics Inc Peroxisome Proliferator Activated Receptor Delta Corporation Information
12.3.2 CymaBay Therapeutics Inc Peroxisome Proliferator Activated Receptor Delta Business Overview and Total Revenue
12.3.3 CymaBay Therapeutics Inc Peroxisome Proliferator Activated Receptor Delta Sales, Revenue and Gross Margin (2015-2020)
12.3.4 CymaBay Therapeutics Inc Peroxisome Proliferator Activated Receptor Delta Products Offered
12.3.5 CymaBay Therapeutics Inc Recent Development
12.4 Genfit SA
12.4.1 Genfit SA Peroxisome Proliferator Activated Receptor Delta Corporation Information
12.4.2 Genfit SA Peroxisome Proliferator Activated Receptor Delta Business Overview and Total Revenue
12.4.3 Genfit SA Peroxisome Proliferator Activated Receptor Delta Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Genfit SA Peroxisome Proliferator Activated Receptor Delta Products Offered
12.4.5 Genfit SA Recent Development
12.5 Inventiva
12.5.1 Inventiva Peroxisome Proliferator Activated Receptor Delta Corporation Information
12.5.2 Inventiva Peroxisome Proliferator Activated Receptor Delta Business Overview and Total Revenue
12.5.3 Inventiva Peroxisome Proliferator Activated Receptor Delta Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Inventiva Peroxisome Proliferator Activated Receptor Delta Products Offered
12.5.5 Inventiva Recent Development
12.6 Mitobridge Inc
12.6.1 Mitobridge Inc Peroxisome Proliferator Activated Receptor Delta Corporation Information
12.6.2 Mitobridge Inc Peroxisome Proliferator Activated Receptor Delta Business Overview and Total Revenue
12.6.3 Mitobridge Inc Peroxisome Proliferator Activated Receptor Delta Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Mitobridge Inc Peroxisome Proliferator Activated Receptor Delta Products Offered
12.6.5 Mitobridge Inc Recent Development
12.7 Nippon Chemiphar Co Ltd
12.7.1 Nippon Chemiphar Co Ltd Peroxisome Proliferator Activated Receptor Delta Corporation Information
12.7.2 Nippon Chemiphar Co Ltd Peroxisome Proliferator Activated Receptor Delta Business Overview and Total Revenue
12.7.3 Nippon Chemiphar Co Ltd Peroxisome Proliferator Activated Receptor Delta Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Nippon Chemiphar Co Ltd Peroxisome Proliferator Activated Receptor Delta Products Offered
12.7.5 Nippon Chemiphar Co Ltd Recent Development
12.8 Senju Pharmaceutical Co Ltd
12.8.1 Senju Pharmaceutical Co Ltd Peroxisome Proliferator Activated Receptor Delta Corporation Information
12.8.2 Senju Pharmaceutical Co Ltd Peroxisome Proliferator Activated Receptor Delta Business Overview and Total Revenue
12.8.3 Senju Pharmaceutical Co Ltd Peroxisome Proliferator Activated Receptor Delta Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Senju Pharmaceutical Co Ltd Peroxisome Proliferator Activated Receptor Delta Products Offered
12.8.5 Senju Pharmaceutical Co Ltd Recent Development
12.9 T3D Therapeutics Inc
12.9.1 T3D Therapeutics Inc Peroxisome Proliferator Activated Receptor Delta Corporation Information
12.9.2 T3D Therapeutics Inc Peroxisome Proliferator Activated Receptor Delta Business Overview and Total Revenue
12.9.3 T3D Therapeutics Inc Peroxisome Proliferator Activated Receptor Delta Sales, Revenue and Gross Margin (2015-2020)
12.9.4 T3D Therapeutics Inc Peroxisome Proliferator Activated Receptor Delta Products Offered
12.9.5 T3D Therapeutics Inc Recent Development

13 Peroxisome Proliferator Activated Receptor Delta Manufacturing Cost Analysis
13.1 Peroxisome Proliferator Activated Receptor Delta Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Peroxisome Proliferator Activated Receptor Delta
13.4 Peroxisome Proliferator Activated Receptor Delta Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Peroxisome Proliferator Activated Receptor Delta Distributors List
14.3 Peroxisome Proliferator Activated Receptor Delta Customers

15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Tables

Table 1. Global Peroxisome Proliferator Activated Receptor Delta Sales (K Pcs) Growth Rate by Type (2020-2026)
Table 2. Global Peroxisome Proliferator Activated Receptor Delta Sales (K Pcs) Comparison by Application (2020-2026)
Table 3. Global Market Peroxisome Proliferator Activated Receptor Delta Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Peroxisome Proliferator Activated Receptor Delta Sales (K Pcs) by Region (2015-2020)
Table 5. Global Peroxisome Proliferator Activated Receptor Delta Sales Market Share by Region (2015-2020)
Table 6. Global Peroxisome Proliferator Activated Receptor Delta Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Peroxisome Proliferator Activated Receptor Delta Revenue Share by Region (2015-2020)
Table 8. Global Peroxisome Proliferator Activated Receptor Delta Sales (K Pcs) Forecast by Region (2021-2026)
Table 9. Global Peroxisome Proliferator Activated Receptor Delta Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Peroxisome Proliferator Activated Receptor Delta Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Peroxisome Proliferator Activated Receptor Delta Revenue Share Forecast by Region (2021-2026)
Table 12. Global Peroxisome Proliferator Activated Receptor Delta (K Pcs) of Key Companies (2015-2020)
Table 13. Global Peroxisome Proliferator Activated Receptor Delta Sales Share by Company (2015-2020)
Table 14. Global Peroxisome Proliferator Activated Receptor Delta Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Peroxisome Proliferator Activated Receptor Delta Revenue Share by Company (2015-2020)
Table 16. Global Peroxisome Proliferator Activated Receptor Delta by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Peroxisome Proliferator Activated Receptor Delta as of 2019)
Table 17. Global Peroxisome Proliferator Activated Receptor Delta Average Price (USD/Pcs) of Key Company (2015-2020)
Table 18. Manufacturers Peroxisome Proliferator Activated Receptor Delta Manufacturing Sites and Area Served
Table 19. Manufacturers Peroxisome Proliferator Activated Receptor Delta Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Peroxisome Proliferator Activated Receptor Delta Players
Table 22. Global Peroxisome Proliferator Activated Receptor Delta Sales (K Pcs) by Type (2015-2020)
Table 23. Global Peroxisome Proliferator Activated Receptor Delta Sales Share by Type (2015-2020)
Table 24. Global Peroxisome Proliferator Activated Receptor Delta Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Peroxisome Proliferator Activated Receptor Delta Price (K Pcs) by Type (2015-2020)
Table 26. Global Peroxisome Proliferator Activated Receptor Delta Sales Share by Type (2021-2026)
Table 27. Global Peroxisome Proliferator Activated Receptor Delta Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Peroxisome Proliferator Activated Receptor Delta Revenue Share by Type (2021-2026)
Table 29. Global Peroxisome Proliferator Activated Receptor Delta Price (K Pcs) by Type (2021-2026)
Table 30. Global Peroxisome Proliferator Activated Receptor Delta Sales (K Pcs) by Application (2015-2020)
Table 31. Global Peroxisome Proliferator Activated Receptor Delta Sales Share by Application (2015-2020)
Table 32. Global Peroxisome Proliferator Activated Receptor Delta Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Peroxisome Proliferator Activated Receptor Delta Price (K Pcs) by Application (2015-2020)
Table 34. Global Peroxisome Proliferator Activated Receptor Delta Sales (K Pcs) by Application (2021-2026)
Table 35. Global Peroxisome Proliferator Activated Receptor Delta Sales Share by Application (2021-2026)
Table 36. Global Peroxisome Proliferator Activated Receptor Delta Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Peroxisome Proliferator Activated Receptor Delta Revenue Share by Application (2021-2026)
Table 38. Global Peroxisome Proliferator Activated Receptor Delta Price (K Pcs) by Application (2021-2026)
Table 39. United States Peroxisome Proliferator Activated Receptor Delta Sales (K Pcs) by Company (2015-2020)
Table 40. United States Peroxisome Proliferator Activated Receptor Delta Sales Market Share by Company (2015-2020)
Table 41. United States Peroxisome Proliferator Activated Receptor Delta Sales (K Pcs) by Type (2015-2020)
Table 42. United States Peroxisome Proliferator Activated Receptor Delta Sales Market Share by Type (2015-2020)
Table 43. United States Peroxisome Proliferator Activated Receptor Delta Sales (K Pcs) by Application (2015-2020)
Table 44. United States Peroxisome Proliferator Activated Receptor Delta Sales Market Share by Application (2015-2020)
Table 45. Europe Peroxisome Proliferator Activated Receptor Delta Sales (K Pcs) by Company (2015-2020)
Table 46. Europe Peroxisome Proliferator Activated Receptor Delta Sales Market Share by Company (2015-2020)
Table 47. Europe Peroxisome Proliferator Activated Receptor Delta Sales (K Pcs) by Type (2015-2020)
Table 48. Europe Peroxisome Proliferator Activated Receptor Delta Sales Market Share by Type (2015-2020)
Table 49. Europe Peroxisome Proliferator Activated Receptor Delta Sales (K Pcs) by Application (2015-2020)
Table 50. Europe Peroxisome Proliferator Activated Receptor Delta Sales Market Share by Type (2015-2020)
Table 51. China Peroxisome Proliferator Activated Receptor Delta Sales (K Pcs) by Company (2015-2020)
Table 52. China Peroxisome Proliferator Activated Receptor Delta Sales Market Share by Company (2015-2020)
Table 53. China Peroxisome Proliferator Activated Receptor Delta Sales (K Pcs) by Type (2015-2020)
Table 54. China Peroxisome Proliferator Activated Receptor Delta Sales Market Share by Type (2015-2020)
Table 55. China Peroxisome Proliferator Activated Receptor Delta Sales (K Pcs) by Application (2015-2020)
Table 56. China Peroxisome Proliferator Activated Receptor Delta Sales Market Share by Application (2015-2020)
Table 57. Japan Peroxisome Proliferator Activated Receptor Delta Sales (K Pcs) by Company (2015-2020)
Table 58. Japan Peroxisome Proliferator Activated Receptor Delta Sales Market Share by Company (2015-2020)
Table 59. Japan Peroxisome Proliferator Activated Receptor Delta Sales (K Pcs) by Type (2015-2020)
Table 60. Japan Peroxisome Proliferator Activated Receptor Delta Sales Market Share by Type (2015-2020)
Table 61. Japan Peroxisome Proliferator Activated Receptor Delta Sales (K Pcs) by Application (2015-2020)
Table 62. Japan Peroxisome Proliferator Activated Receptor Delta Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Peroxisome Proliferator Activated Receptor Delta Sales (K Pcs) by Company (2015-2020)
Table 64. Southeast Asia Peroxisome Proliferator Activated Receptor Delta Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Peroxisome Proliferator Activated Receptor Delta Sales (K Pcs) by Type (2015-2020)
Table 66. Southeast Asia Peroxisome Proliferator Activated Receptor Delta Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Peroxisome Proliferator Activated Receptor Delta Sales (K Pcs) by Type (2015-2020)
Table 68. Southeast Asia Peroxisome Proliferator Activated Receptor Delta Sales Market Share by Application (2015-2020)
Table 69. India Peroxisome Proliferator Activated Receptor Delta Sales (K Pcs) by Company (2015-2020)
Table 70. India Peroxisome Proliferator Activated Receptor Delta Sales Market Share by Company (2015-2020)
Table 71. India Peroxisome Proliferator Activated Receptor Delta Sales (K Pcs) by Type (2015-2020)
Table 72. India Peroxisome Proliferator Activated Receptor Delta Sales Market Share by Type (2015-2020)
Table 73. India Peroxisome Proliferator Activated Receptor Delta Sales (K Pcs) by Application (2015-2020)
Table 74. India Peroxisome Proliferator Activated Receptor Delta Sales Market Share by Application (2015-2020)
Table 75. Chipscreen Biosciences Ltd Corporation Information
Table 76. Chipscreen Biosciences Ltd Description and Business Overview
Table 77. Chipscreen Biosciences Ltd Peroxisome Proliferator Activated Receptor Delta Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 78. Chipscreen Biosciences Ltd Peroxisome Proliferator Activated Receptor Delta Product
Table 79. Chipscreen Biosciences Ltd Recent Development
Table 80. Connexios Life Sciences Pvt Ltd Corporation Information
Table 81. Connexios Life Sciences Pvt Ltd Description and Business Overview
Table 82. Connexios Life Sciences Pvt Ltd Peroxisome Proliferator Activated Receptor Delta Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 83. Connexios Life Sciences Pvt Ltd Peroxisome Proliferator Activated Receptor Delta Product
Table 84. Connexios Life Sciences Pvt Ltd Recent Development
Table 85. CymaBay Therapeutics Inc Corporation Information
Table 86. CymaBay Therapeutics Inc Description and Business Overview
Table 87. CymaBay Therapeutics Inc Peroxisome Proliferator Activated Receptor Delta Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 88. CymaBay Therapeutics Inc Peroxisome Proliferator Activated Receptor Delta Product
Table 89. CymaBay Therapeutics Inc Recent Development
Table 90. Genfit SA Corporation Information
Table 91. Genfit SA Description and Business Overview
Table 92. Genfit SA Peroxisome Proliferator Activated Receptor Delta Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 93. Genfit SA Peroxisome Proliferator Activated Receptor Delta Product
Table 94. Genfit SA Recent Development
Table 95. Inventiva Corporation Information
Table 96. Inventiva Description and Business Overview
Table 97. Inventiva Peroxisome Proliferator Activated Receptor Delta Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 98. Inventiva Peroxisome Proliferator Activated Receptor Delta Product
Table 99. Inventiva Recent Development
Table 100. Mitobridge Inc Corporation Information
Table 101. Mitobridge Inc Description and Business Overview
Table 102. Mitobridge Inc Peroxisome Proliferator Activated Receptor Delta Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 103. Mitobridge Inc Peroxisome Proliferator Activated Receptor Delta Product
Table 104. Mitobridge Inc Recent Development
Table 105. Nippon Chemiphar Co Ltd Corporation Information
Table 106. Nippon Chemiphar Co Ltd Description and Business Overview
Table 107. Nippon Chemiphar Co Ltd Peroxisome Proliferator Activated Receptor Delta Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 108. Nippon Chemiphar Co Ltd Peroxisome Proliferator Activated Receptor Delta Product
Table 109. Nippon Chemiphar Co Ltd Recent Development
Table 110. Senju Pharmaceutical Co Ltd Corporation Information
Table 111. Senju Pharmaceutical Co Ltd Peroxisome Proliferator Activated Receptor Delta Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 112. Senju Pharmaceutical Co Ltd Description and Business Overview
Table 113. Senju Pharmaceutical Co Ltd Peroxisome Proliferator Activated Receptor Delta Product
Table 114. Senju Pharmaceutical Co Ltd Recent Development
Table 115. T3D Therapeutics Inc Corporation Information
Table 116. T3D Therapeutics Inc Peroxisome Proliferator Activated Receptor Delta Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 117. T3D Therapeutics Inc Description and Business Overview
Table 118. T3D Therapeutics Inc Peroxisome Proliferator Activated Receptor Delta Product
Table 119. T3D Therapeutics Inc Recent Development
Table 120. Production Base and Market Concentration Rate of Raw Material
Table 121. Key Suppliers of Raw Materials
Table 122. Peroxisome Proliferator Activated Receptor Delta Distributors List
Table 123. Peroxisome Proliferator Activated Receptor Delta Customers List
Table 124. Market Key Trends
Table 125. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 126. Key Challenges
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Peroxisome Proliferator Activated Receptor Delta Product Picture
Figure 2. Global Peroxisome Proliferator Activated Receptor Delta Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Peroxisome Proliferator Activated Receptor Delta Market Share by Application in 2020 & 2026
Figure 6. Bone Disorders Examples
Figure 7. Colitis Examples
Figure 8. Obesity Examples
Figure 9. Osteoporosis Examples
Figure 10. Others Examples
Figure 11. Global Peroxisome Proliferator Activated Receptor Delta Sales (K Pcs) Growth Rate (2015-2026)
Figure 12. Global Peroxisome Proliferator Activated Receptor Delta Revenue (US$ Million) Growth Rate (2015-2026)
Figure 13. Global Peroxisome Proliferator Activated Receptor Delta Price Trends Growth Rate (2015-2026) (USD/Pcs)
Figure 14. Global Peroxisome Proliferator Activated Receptor Delta Revenue Market Share by Region: 2015 VS 2020
Figure 15. Global Peroxisome Proliferator Activated Receptor Delta Revenue Market Share by Region: 2021 VS 2026
Figure 16. United States Peroxisome Proliferator Activated Receptor Delta Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. United States Peroxisome Proliferator Activated Receptor Delta Sales (K Pcs) Growth Rate (2015-2026)
Figure 18. Europe Peroxisome Proliferator Activated Receptor Delta Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. Europe Peroxisome Proliferator Activated Receptor Delta Sales (Million USD) Growth Rate (2015-2026)
Figure 20. China Peroxisome Proliferator Activated Receptor Delta Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. China Peroxisome Proliferator Activated Receptor Delta Sales (Million USD) and Growth Rate (2015-2026)
Figure 22. Japan Peroxisome Proliferator Activated Receptor Delta Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Japan Peroxisome Proliferator Activated Receptor Delta Sales (Million USD) Growth Rate (2015-2026)
Figure 24. Southeast Asia Peroxisome Proliferator Activated Receptor Delta Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. Southeast Asia Peroxisome Proliferator Activated Receptor Delta Sales (Million USD) Growth Rate (2015-2026)
Figure 26. India Peroxisome Proliferator Activated Receptor Delta Revenue (Million USD) Growth Rate (2015-2026)
Figure 27. India Peroxisome Proliferator Activated Receptor Delta Sales (Million USD) Growth Rate (2015-2026)
Figure 28. Global 5 Largest Peroxisome Proliferator Activated Receptor Delta Players Market Share by Revenue in Peroxisome Proliferator Activated Receptor Delta 2015 & 2019
Figure 29. Peroxisome Proliferator Activated Receptor Delta Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 30. Global Peroxisome Proliferator Activated Receptor Delta Revenue Share by Type (2015-2020)
Figure 31. Global Peroxisome Proliferator Activated Receptor Delta Revenue Growth Rate by Type in 2015 & 2019
Figure 32. Global Peroxisome Proliferator Activated Receptor Delta Revenue Share by Application (2015-2020)
Figure 33. Global Peroxisome Proliferator Activated Receptor Delta Revenue Growth Rate by Application in 2015 & 2019
Figure 34. United States Peroxisome Proliferator Activated Receptor Delta Sales Market Share by Type in 2019
Figure 35. United States Peroxisome Proliferator Activated Receptor Delta Sales Market Share by Type in 2019
Figure 36. Europe Peroxisome Proliferator Activated Receptor Delta Sales Market Share by Company in 2019
Figure 37. Europe Peroxisome Proliferator Activated Receptor Delta Sales Market Share by Type in 2019
Figure 38. Europe Peroxisome Proliferator Activated Receptor Delta Sales Market Share by Application in 2019
Figure 39. China Peroxisome Proliferator Activated Receptor Delta Sales Market Share by Company in 2019
Figure 40. China Peroxisome Proliferator Activated Receptor Delta Sales Market Share by Type in 2019
Figure 41. China Peroxisome Proliferator Activated Receptor Delta Sales Market Share by Application in 2019
Figure 42. Japan Peroxisome Proliferator Activated Receptor Delta Sales Market Share by Company in 2019
Figure 43. Japan Peroxisome Proliferator Activated Receptor Delta Sales Market Share by Type in 2019
Figure 44. Japan Peroxisome Proliferator Activated Receptor Delta Sales Market Share by Application in 2019
Figure 45. Southeast Asia Peroxisome Proliferator Activated Receptor Delta Sales Market Share by Company in 2019
Figure 46. Southeast Asia Peroxisome Proliferator Activated Receptor Delta Sales Market Share by Type in 2019
Figure 47. Southeast Asia Peroxisome Proliferator Activated Receptor Delta Sales Market Share by Application in 2019
Figure 48. India Peroxisome Proliferator Activated Receptor Delta Sales Market Share by Company in 2019
Figure 49. India Peroxisome Proliferator Activated Receptor Delta Sales Market Share by Type in 2019
Figure 50. India Peroxisome Proliferator Activated Receptor Delta Sales Market Share by Application in 2019
Figure 51. Chipscreen Biosciences Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Connexios Life Sciences Pvt Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. CymaBay Therapeutics Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Genfit SA Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Inventiva Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Mitobridge Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Nippon Chemiphar Co Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Senju Pharmaceutical Co Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. T3D Therapeutics Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Key Raw Materials Price Trend
Figure 61. Manufacturing Cost Structure of Peroxisome Proliferator Activated Receptor Delta
Figure 62. Manufacturing Process Analysis of Peroxisome Proliferator Activated Receptor Delta
Figure 63. Peroxisome Proliferator Activated Receptor Delta Industrial Chain Analysis
Figure 64. Channels of Distribution
Figure 65. Distributors Profiles
Figure 66. Porter's Five Forces Analysis
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed

---